Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy
Qingsheng Li, Phuong Ngo, Nejat K. Egilmez
Topics & Concepts
CD8BlockadeCytotoxic T cellCTL*Cancer researchImmune checkpointLung cancerT cellMedicineAntibodyImmune systemImmunotherapyImmunologyBiologyInternal medicineReceptorBiochemistryIn vitroCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesImmune Cell Function and Interaction